Status | Study |
Active, not recruiting |
Study Name: Nilotinib With Radiation for High Risk Chordoma Condition: Chordoma Date: 2011-07-28 Interventions: Drug: Nilotinib Orally, daily |
Active, not recruiting |
Study Name: High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull Condition: Chordoma of Spine Chordoma of Sacr Date: 2011-04-28 Interventions: Radiation: High Dose Intensity Modulated Proton Radiation Radiation given once a day Monday-Friday |
Recruiting |
Study Name: Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes Condition: Genes Sporadic Chordoma Date: 2010-09-09 |
Active, not recruiting |
Study Name: Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma Condition: Chordoma Date: 2010-07-28 Interventions: Drug: Imatinib + LBH589 Escalating doses of imatinib and LBH589 will be administered. |
Recruiting |
Study Name: Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base Condition: Chordoma Tumor Treatment Date: 2010-07-26 Interventions: Radiation: Carbon ion |
Completed |
Study Name: Proton Therapy for Chordomas and/or Chondrosarcomas Condition: Chordomas Chondrosarcomas Date: 2008-11-24 |
Completed |
Study Name: Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas Condition: Chordoma Date: 2008-07-09 Interventions: Procedure: Fluoromisonidazole-PET/CT 2 scans at different time intervals: 2 weeks before and 3 weeks aft |
Recruiting |
Study Name: Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine Condition: Chordoma Chondrosarcoma Date: 2007-12-28 Interventions: Radiation: Charged Particle Radiation Therapy Radiation doses will be determined by planning CT |
Active, not recruiting |
Study Name: Proton Beam Therapy for Chordoma Patients Condition: Chordoma Date: 2007-07-02 Interventions: Radiation: Proton Beam Therapy |
Active, not recruiting |
Study Name: Trial of Dasatinib in Advanced Sarcomas Condition: Rhabdomyosarcoma Malignant Peripheral Nerve Sheath Tumors Date: 2007-04-20 Interventions: Drug: Dasatinib oral agent, continuous dosing, Cycles = 28 days |